Neupro 3 mg/24h, dispositif transdermique

7680574170328 CH-57417 dispositif transdermique
Neupro 3 mg/24h, dispositif transdermique
Neupro 3 mg/24h, dispositif transdermique
Neupro 3 mg/24h, dispositif transdermique
1 / 3
google

Article details

Package size
7
Selling units
7
Measure
Pflaster
Galenic form
dispositif transdermique
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
18/07/2024
Patient information leaflet
Français
18/07/2024
Patient information leaflet
Italien
18/07/2024
Summary of Product Characteristics
Allemand
18/07/2024
Summary of Product Characteristics
Français
18/07/2024
Summary of Product Characteristics
Italien
18/07/2024

Detailed composition

Substance Quantity Type Category
(N/A)
6.75 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance ANTOX
(N/A)
- Substance ANTOX
(N/A)
- Substance ANTOX
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 34.55
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2010

Authorization holder

UCB-Pharma SA

1630 Bulle

Authorization information

Swissmedic authorization number
57417
Drug name
Neupro, dispositif transdermique
Galenic form
TRAP
ATC Code
N04BC09
Authorization status
Z
Dispensing category
B
First authorization
27/09/2006
Authorization expiration date
31/12/9999
IT Number
01.08.0.
Domain
Human medicine

Package details

Description (FR)
NEUPRO patch mat 3 mg/24h sach 7 pce
Description (DE)
NEUPRO Matrixpfl 3 mg/24h Btl 7 Stk
Market launch
05/03/2014
Narcotic (BTM)
No

Other package sizes (10)

None
7 PFLA
GTIN: None
Not in V1
None
28 PFLA
GTIN: None
Not in V1
None
7 PFLA
GTIN: None
Not in V1
None
28 PFLA
GTIN: None
Not in V1
None
7 PFLA
GTIN: None
Not in V1
None
28 PFLA
GTIN: None
Not in V1
None
28 PFLA
GTIN: None
Not in V1
None
7 PFLA
GTIN: None
Not in V1
None
28 PFLA
GTIN: None
Not in V1
None
7 PFLA
GTIN: None
Not in V1